Ładuje się......
Psychiatric symptoms and synthetic cannabinoid use: Information for clinicians
BACKGROUND: Limited treatment information is available when patients present with psychotic symptoms secondary to synthetic cannabinoid (SC) use. Symptoms associated with use are often indistinguishable from those encountered with a primary mental illness and also include aggression, confusion, and...
Zapisane w:
| Wydane w: | Ment Health Clin |
|---|---|
| Główni autorzy: | , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
College of Psychiatric & Neurologic Pharmacists
2018
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6007529/ https://ncbi.nlm.nih.gov/pubmed/29955515 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9740/mhc.2017.07.156 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|